Publications by authors named "Judith Pirngruber"

Claim this Profile
T
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations.
Balázs Jóri, Christine Vössing, Judith Pirngruber, Eva Maria Willing, Kathrin Arndt

Curr Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation.
Eva-Maria Willing, Claudia Vollbrecht, Christine Vössing, Peggy Weist, Simon Schallenberg, Judith Pirngruber

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.
Efrat Shema, Itay Tirosh, Yael Aylon, Jing Huang, Chaoyang Ye, Judith Pirngruber

Genes Dev· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKC{alpha} is essential for the proper activation and termination of rod bipolar cell response.
Klaus Ruether, Andreas Feigenspan, Judith Pirngruber, Michael Leitges, Wolfgang Baehr

Invest Ophthalmol Vis Sci· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing.
Judith Pirngruber, Andrei Shchebet, Steven A Johnsen

Cell Cycle· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing.
Judith Pirngruber, Andrei Shchebet, Lisa Schreiber, Efrat Shema, Neri Minsky

EMBO Rep· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.
Ines Ecke, Frauke Petry, Albert Rosenberger, Svantje Tauber, Sven Mönkemeyer, Judith Pirngruber

Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.
Efrat Shema, Itay Tirosh, Yael Aylon, Jing Huang, Chaoyang Ye, Judith Pirngruber

Genes Dev· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis